Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/40171
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLedeboer, A.en
dc.contributor.authorHutchinson, M.en
dc.contributor.authorWatkins, L.en
dc.contributor.authorJohnson, K.en
dc.date.issued2007en
dc.identifier.citationExpert Opinion on Investigational Drugs, 2007; 16(7):935-950en
dc.identifier.issn1354-3784en
dc.identifier.issn1744-7658en
dc.identifier.urihttp://hdl.handle.net/2440/40171-
dc.description© 2007 Informa UK Limiteden
dc.description.abstractThe treatment of neuropathic pain is a major unresolved medical challenge. Present pharmacotherapies only have modest efficacy and numerous side effects. The use of opioid analgesics is additionally coupled with dependence and withdrawal syndromes. Ibudilast (AV-411) is a non-selective phosphodiesterase inhibitor that is also known to suppress glial cell activation. It has been used clinically for other indications with a good safety profile. As glial cell activation is considered to crucially contribute to neuropathic pain as well as opioid dependence and withdrawal, the authors conceived that ibudilast may be useful for treating these conditions. Preclinical data indicate that ibudilast crosses the blood-brain barrier, is well tolerated, is active on oral administration, reduces glial activation and attenuates pain symptoms in diverse rat models of neuropathic pain. In addition, it enhances acute morphine analgesia and attenuates morphine tolerance and withdrawal. Thus ibudilast may improve opioid efficacy and is a promising therapeutic candidate for neuropathic pain, with a novel mechanism of action.en
dc.format.extent3033625 bytesen
dc.format.mimetypeapplication/pdfen
dc.language.isoenen
dc.publisherAshley Publications Ltden
dc.subjectanalgesia; astroglia; cytokine; ibudilast; microglia; neuropathic pain; opioids; phosphodiesterase inhibitor; withdrawalen
dc.titleIbudilast (AV-411): A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromesen
dc.typeJournal articleen
dc.identifier.rmid0020071177en
dc.identifier.doi10.1517/13543784.16.7.935en
dc.identifier.pubid48573-
pubs.library.collectionMedical Sciences publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
Appears in Collections:Medical Sciences publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.